In conclusion, curcumin inhibits lung cancer growth through, at least in part, the inhibition of EZH2 and its reciprocally regulated molecule NOTCH1, suggesting that the molecules that are involved in the EZH2/NOTCH signaling pathway are potential therapeutic targets for lung cancer. This evidence concerns the gene NOTCH1 and lung carcinoma.